sumi.news
Search
Following
Sign in
← Back to news
S
Seeking Alpha: Popular
RSS Feed
seekingalpha.com
seekingalpha.com/listing/most-popular-articles.xml
Follow
Latest
Mon Jun 2
AMD Stock Continues To Be A No Brainer (Technical Analysis)
3w
S
Snowflake: I'm Still Unconvinced (Technical Analysis, Rating Upgrade)
3w
S
Altria Group: Big Issues Necessitate Caution
3w
S
OppFi: Undervalued, Underrated Fintech With Unconventional Upside
3w
S
The Big 4 Recession Indicators: May Employment
3w
S
Argan: The Real Growth May Still Be Ahead, I Am Reiterating Buy
3w
S
Bill Ackman Loves Brookfield Asset Management, And So Do I
3w
S
Buy These 2 Passive Income Machines On Sale Now
3w
S
Palantir: Step Aside AI Models, The Next Big Thing Is AI Agents
3w
S
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 10% (June 2025)
3w
S
Your Retirement Starts Here: 2 Dividend Gems I'd Trust With My Future
3w
S
The More It Drops, The More I Buy
3w
S
June's Top Dividend Aristocrat Fat Pitches: Blue-Chip Bargains You Can't Miss
3w
S
What Moved Markets This Week
3w
S
Dividend Champion, Contender, And Challenger Highlights: Week Of June 8
3w
S
Nvidia Back In Focus And AI Infrastructure Acceleration
3w
S
Realty Income Is Better Than Simon Property After U.S. Credit Rating Downgrade
3w
S
ATRenew: Old Phones, New Profits
3w
S
DXP Enterprises: Hold Rating As Macro Challenges Offset EBITDA Upside
3w
S
Markets Weekly Outlook - U.S. Inflation On Deck As Trade Uncertainty Lingers
3w
S
Politics And The Markets 06/07/25
3w
S
The Simple Path To Wealth With 2 Buy And Hold 'Forever' ETFs
3w
S
Nvidia: I Predicted $150 By Year End - I Was Dead Wrong
3w
S
Power Up Your Portfolio With Reliable Dividends; Yields +10%
3w
S
Musk And Trump Fight Goes Off The Rails
3w
S
Dividend Investors Beware: A Monumental Market Shift You Can't Ignore
3w
S
A Major Market Reversal Is Likely Coming
3w
S
3 Passive 'SWAN' Stocks (Hint: They're Not REITs)
3w
S
Credo: Wiring The AI Infrastructure Of Hyperscalers Leads To Rapid Growth
3w
S
Amgen's Strategic Path - Navigating Patent Expiries With Promising New Therapies
3w
S
Broadcom's Post-Q2 Earnings Pullback Is A Classic Overreaction
3w
S
Whitehaven Coal: Caught In The Political Crossfire
3w
S
ChargePoint: Weak Quarter And Disappointing Outlook - Sell (Rating Downgrade)
3w
S
DocuSign Q1: Lowered Billing Growth Is Just Renewal Timing Issue
3w
S
Wall Street Lunch: Tesla Losing A Trump Put?
3w
S
Tesla's Imminent Valuation Crash?
3w
S
Sell Alert: 3 REITs That May Cut Their Dividend
3w
S
My Latest Buy Yields 21%: ECC
3w
S
No Guts, No Glory - 2 Of My Favorite Dividend Stocks For Serious Wealth
3w
S
Next Button Pressed In The Console Wars
3w
S
Nebius: Explosive Growth At What Is Still A Reasonable Valuation
3w
S
Top 10 Quant Stocks Of 2025: Up 22%
1mo
S
Brookfield Asset Management Uncovers Hidden Value From Infrastructure And AI
1mo
S
Palantir: Don't Fool Yourself, The Euphoria Is Justified
1mo
S
Arcutis Biotherapeutics: Navigating Commercialization With Promising Upside
1mo
S
Trump Ignores The Markets' Warning At Our Economic Peril
1mo
S
Celestica: Significantly Overvalued For A No-Moat Company
1mo
S
Civitas Resources: Debt Maturities Should Be Manageable After Latest Bond Offering
1mo
S
Dividends A Fallacy? This Is My $3,000 Per Month Response
1mo
S
'The Big Short' Michael Burry's Latest Moves: What Investors Are Getting Wrong
1mo
S
More →